Literature DB >> 15013717

Side-to-side isoperistaltic strictureplasty in the treatment of extensive Crohn's disease.

Fabrizio Michelassi1, Gaurav A Upadhyay.   

Abstract

BACKGROUND: First performed in 1992, the side-to-side isoperistaltic strictureplasty (SSIS) is a bowel-sparing surgical option for Crohn's patients presenting with sequentially occurring stenoses over long intestinal segments (>15 cm). This investigation was designed to study the outcomes and patterns of recurrence after a SSIS.
MATERIALS AND METHODS: Between 1992 and 2003, 30 patients underwent SSIS at the University of Chicago. Their data were gathered prospectively in an Institutional Review Board-approved database.
RESULTS: A total of 31 SSISs were constructed in 30 patients. As an indication of the severity of disease in these patients, 25 of 30 (83%) required a concomitant bowel resection, and 13 (43%) underwent at least one additional strictureplasty. The average length of diseased bowel used to construct the SSIS was 51 cm. The average length of residual small bowel after performance of SSIS was 275 cm, and the SSIS represented an average 19% of the remaining small bowel that would have otherwise been sacrificed with resection. Three patients experienced perioperative complications (10%) and one died (3%). Seven patients (23%) required reoperation to treat recurrence of symptoms within the first 5 years. In four of these patients, recurrence was found at or near the previous SSIS.
CONCLUSIONS: A side-to-side isoperistaltic strictureplasty (SSIS) is a safe and effective surgical option for sequentially occurring Crohn's strictures over long intestinal segments.

Entities:  

Mesh:

Year:  2004        PMID: 15013717     DOI: 10.1016/j.jss.2003.11.008

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  A think tank of the Italian society of colorectal surgery (SICCR) on the surgical treatment of inflammatory bowel disease using the Delphi method: Crohn's disease.

Authors:  G Pellino; F Selvaggi; G Ghezzi; D Corona; G Riegler; G G Delaini
Journal:  Tech Coloproctol       Date:  2015-09-24       Impact factor: 3.781

2.  European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

Authors:  S P L Travis; E F Stange; M Lémann; T Oresland; Y Chowers; A Forbes; G D'Haens; G Kitis; A Cortot; C Prantera; P Marteau; J-F Colombel; P Gionchetti; Y Bouhnik; E Tiret; J Kroesen; M Starlinger; N J Mortensen
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

Review 3.  Multidisciplinary management of gastrointestinal fibrotic stenosis in Crohn's disease.

Authors:  Brice Malgras; Karine Pautrat; Xavier Dray; Pierre Pasquier; Patrice Valleur; Marc Pocard; Philippe Soyer
Journal:  Dig Dis Sci       Date:  2014-11-08       Impact factor: 3.199

4.  Is lymphatic status related to regression of inflammation in Crohn's disease?

Authors:  Francesco Tonelli; Francesco Giudici; Gadiel Liscia
Journal:  World J Gastrointest Surg       Date:  2012-10-27

Review 5.  Surgical Considerations in the Treatment of Small Bowel Crohn's Disease.

Authors:  Lillias Holmes Maguire; Karim Alavi; Ranjan Sudan; Paul E Wise; Andreas M Kaiser; Liliana Bordeianou
Journal:  J Gastrointest Surg       Date:  2016-12-13       Impact factor: 3.452

Review 6.  Crohn's disease: a surgeon's perspective.

Authors:  Fazl Q Parray; Mohd Lateef Wani; Akram H Bijli; Natasha Thakur; Ifat Irshad
Journal:  Saudi J Gastroenterol       Date:  2011 Jan-Feb       Impact factor: 2.485

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.